lascondes_28_03

93 / 154

419
al. Congress of Neurological Surgeons Systematic Review and
Evidence-Based Guidelines on the Management of Patients
With Nonfunctioning Pituitary Adenomas: Executive Summary.
Neurosurgery. 2016 Oct;79(4):521–3.
7. Rojas Z D, Palma F A, Wohllk G N. Manejo de los adenomas
hipofisiarios. Rev Chil Neuro-Psiquiatr [Internet]. 2008
Jun [cited 2016 Aug 23];46(2). Available from: http://
92272008000200009&lng=en&nrm=iso&tlng=en
8. Molitch ME. Pituitary incidentalomas. Best Pract Res Clin
Endocrinol Metab. 2009 Oct;23(5):667–75.
9. Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM,
Post KD, et al. Pituitary Incidentaloma: An Endocrine Society
Clinical Practice Guideline. J Clin Endocrinol Metab. 2011
Apr;96(4):894–904.
10. Fernández V, Schweitze, Mariana, Hempel, Margrit. Atlas
de campo visual. Depto. Neuro-oftalmología. Instituto de
Neurocirugía Asemjo; 2015.
11. Kedar S, Ghate D, Corbett J. Visual fields in neuro-
ophthalmology. Indian J Ophthalmol. 2011;59(2):103.
12. Oldfield EH, Merrill MJ. Apoplexy of pituitary adenomas: the
perfect storm. J Neurosurg. 2015 Jun;122(6):1444–9.
13. Verrees M, Arafah BM, Selman WR. Pituitary tumor apoplexy:
characteristics, treatment, and outcomes. Neurosurg Focus.
2004 Apr 15;16(4):E6.
14. Mehta GU, Lonser RR. Management of hormone-secreting
pituitary adenomas. Neuro-Oncol. 2016 Aug 19;now130.
15. Bonneville J-F. Magnetic Resonance Imaging of Pituitary
Tumors. In: Buchfelder M, Guaraldi F, editors. Frontiers of
Hormone Research. S. Karger AG; 2016. p. 97–120.
16. Newman SA, Turbin RE, Bodach ME, Tumialan LM, Oyesiku NM,
Litvack Z, et al. Congress of Neurological Surgeons Systematic
Review and Evidence-Based Guideline on Pretreatment
Ophthalmology Evaluation in Patients With Suspected
Nonfunctioning Pituitary Adenomas: Neurosurgery. 2016
Oct;79(4):E530–2.
17. Chen CC, Carter BS, Wang R, Patel KS, Hess C, Bodach ME, et
al. Congress of Neurological Surgeons Systematic Review and
Evidence-Based Guideline on Preoperative Imaging Assessment
of Patients With Suspected Nonfunctioning Pituitary Adenomas:
Neurosurgery. 2016 Oct;79(4):E524–6.
18. Fleseriu M, Bodach ME, Tumialan LM, Bonert V, Oyesiku NM,
Patil CG, et al. Congress of Neurological Surgeons Systematic
Review and Evidence-Based Guideline for Pretreatment
Endocrine Evaluation of Patients With Nonfunctioning Pituitary
Adenomas: Neurosurgery. 2016 Oct;79(4):E527–9.
19. Carrasco CA, García M, Goycoolea M, Cerda J, Bertherat J, Padilla
O, et al. Reproducibility and performance of one or two samples
of salivary cortisol in the diagnosis of Cushing’s syndrome
using an automated immunoassay system. Endocrine. 2012
Jun;41(3):487–93.
20. T. Red, L. JV, G. NW. Laboratorio de hormonas: aspectos prácticos.
Rev Médica Clínica Las Condes. 2015 Nov;26(6):776–87.
21. Rojas-Zalazar D, Mura C J, Cataldo G C, Wohllk G N. Manejo
multidisciplinario de la acromegalia. Rev Chil Neuro-Psiquiatr.
2011 Mar;49(1):37–46.
22. Cuevas JL, Fernández V, Rojas D, Wohllk N, González Ó, Torche
E. Resultados visuales en pacientes con macroprolactinoma
tratados con agonistas de dopamina. Rev Médica Chile. 2013
Jun;141(6):687–94.
23. Lucas JW, Bodach ME, Tumialan LM, Oyesiku NM, Patil CG,
Litvack Z, et al. Congress of Neurological Surgeons Systematic
Review and Evidence-Based Guideline on Primary Management
of Patients With Nonfunctioning Pituitary Adenomas:
Neurosurgery. 2016 Oct;79(4):E533–5.
24. Liu JK, Das K, Weiss MH, Laws ER, Couldwell WT. The history
and evolution of transsphenoidal surgery. J Neurosurg. 2001
Dec;95(6):1083–96.
25. Jho HD, Carrau RL. Endoscopy assisted transsphenoidal surgery
for pituitary adenoma. Technical note. Acta Neurochir (Wien).
1996;138(12):1416–25.
26. Jankowski R, Auque J, Simon C, Marchal JC, Hepner H, Wayoff M.
Endoscopic pituitary tumor surgery. The Laryngoscope. 1992
Feb;102(2):198–202.
27. Starke RM, Raper DMS, Payne SC, Vance ML, Oldfield EH, Jane
JA. Endoscopic vs Microsurgical Transsphenoidal Surgery for
Acromegaly: Outcomes in a Concurrent Series of Patients Using
Modern Criteria For Remission. J Clin Endocrinol Metab. 2013
Aug;98(8):3190–8.
28. Kuo JS, Barkhoudarian G, Farrell CJ, Bodach ME, Tumialan
LM, Oyesiku NM, et al. Congress of Neurological Surgeons
Systematic Review and Evidence-Based Guideline on Surgical
Techniques and Technologies for the Management of Patients
With Nonfunctioning Pituitary Adenomas: Neurosurgery. 2016
Oct;79(4):E536–8.
29. Sheehan J, Lee C-C, Bodach ME, Tumialan LM, Oyesiku NM,
Patil CG, et al. Congress of Neurological Surgeons Systematic
Review and Evidence-Based Guideline for the Management of
Patients With Residual or Recurrent Nonfunctioning Pituitary
Adenomas: Neurosurgery. 2016 Oct;79(4):E539–40.
30. Melmed S, Colao A, Barkan A, Molitch M, Grossman AB,
Kleinberg D, et al. Guidelines for Acromegaly Management: An
Update. J Clin Endocrinol Metab. 2009 May;94(5):1509–17.
31. Kim MY, Kim JH, Oh YK, Kim E. Long-term outcomes of surgery
and radiotherapy for secreting and non-secreting pituitary
adenoma. Radiat Oncol J. 2016 Jun 30;34(2):121–7.
32. Ziu M, Dunn IF, Hess C, Fleseriu M, Bodach ME, Tumialan LM,
et al. Congress of Neurological Surgeons Systematic Review
and Evidence-Based Guideline on Posttreatment Follow-up
Evaluation of Patients With Nonfunctioning Pituitary
Adenomas: Neurosurgery. 2016 Oct;79(4):E541–3.
33. Carrasco CA, Villanueva G P. Criterios para la indicación selectiva
de glucocorticoides en pacientes con tumores hipofisiarios
sometidos a cirugía transesfenoidal. Rev Médica Chile. 2014
Sep;142(9):1113–9.
34. Oldfield EH. Surgical management of Cushing’s disease: a
personal perspective. Clin Neurosurg. 2011;58:13–26.
[MANEJO DE LOS TUMORES DE HIPÓFISIS - Dr. David Rojas]